NORD: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Premium & Copay): Waitist

Funded
About
The NORD: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Premium & Copay): Waitist program provides critical support for patients managing CIDP by assisting with insurance premiums and copays. This program covers a wide range of essential medications, including Gammagard Liquid, Gamunex-C, and others. With the focus on easing the financial burden, the NORD program ensures patients can focus on their treatment without additional financial stress.
Insurance requirements: Commercially insured, Medicare / Medicaid
Enrollment Forms
Enrollment Form
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
Please note the following:
1. Program offers assistance with insurance premiums and copays only
2. Specific drug coverage is not indicated on program website; drug coverage must be verified by calling program
3. Specialty Pharmacy representatives/case managers can send new referrals through the referral portal (https://rareaccess.org/#/login). Representatives must be preregistered by sending a request to RareAccess@rarediseases.org. Representatives can also email the program email address. To make the problem resolution quicker and more efficient please do not send messages to individual emails. If the matter is URGENT, please reach out to SP account manager for NORD to escalate the issue
Patients may apply online, call (2032679005) or email (CIDP@rarediseases.org) program to enroll
Awards are made for a calendar year, and patients may reapply for subsequent years
NORD is able to offer same day approval for programs
Patients must undergo a financial evaluation of need, and provide HIPPA authorization and accept a waiver of liability
Fax number for program is 2032661002
Other Programs
Accessia Health: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Private Insurance
HyQvia at no costSee program details for eligibility
Assistance Fund: Activated Phosphoinositide 3-kinase Delta Syndrome (APDS)
HyQvia at no costSee program details for eligibility
Other Tools for HyQvia